Fanconi anemia is a rare genetic disorder characterized by bone marrow failure and a predisposition to developing cancer. The current treatments include blood transfusions, antibiotics, antifungals, immunosuppressive drugs, chemotherapy, stem cell or bone marrow transplants. The global fanconi anemia drug market is still in a nascent stage with only one drug currently approved by FDA and EMA...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian